Dodecane

Dodecane

SCHEMBL4530976

C=CC=C.CCCCCCCCCCCC

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.61
THRB P10828 1/20 0.61
ALDH1A1 P00352 4/20 0.50
DNM1 Q05193 5/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC22A1 O15245 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Heptane SCHEMBL11697610 1.00 TSHR (0.61) TSHRTHRBALDH1A1DNM1LMNA
Decane SCHEMBL4518816 1.00 TSHR (0.61) TSHRTHRBALDH1A1DNM1LMNA
Octane SCHEMBL4515243 1.00 TSHR (0.61) TSHRTHRBALDH1A1DNM1LMNA
Hexane SCHEMBL2147506 0.96 TSHR (0.56) TSHRTHRBALDH1A1DNM1LMNA
Hexane SCHEMBL28322670 0.96 TSHR (0.56) TSHRTHRBALDH1A1DNM1LMNA
Hexane SCHEMBL9348352 0.92 TSHR (0.53) TSHRTHRBALDH1A1DNM1LMNA
Dodecane SCHEMBL3718337 0.90 TSHR (0.52) TSHRTHRBALDH1A1LMNAMEN1
Pentane SCHEMBL8136471 0.88
Hexane SCHEMBL10533796 0.86 TSHR (0.48) TSHRTHRBALDH1A1LMNAMEN1
Butadiene SCHEMBL382147 0.85 TSHR (0.72) TSHRTHRBALDH1A1DNM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109562029-A System for dispensing a cosmetic product 欧莱雅 2019-04-02 CN disclosed
US-20090117160-A1 Compositions for Making up Keratinous Materials L 'OREAL (FR) 2009-05-07 US disclosed
US-20090041696-A1 Compositions for Making Up Keratinous Materials L'OREAL (FR) 2009-02-12 US disclosed
US-20090041695-A1 Compositions for making up keratinous materials L'OREAL (FR) 2009-02-12 US disclosed
US-20080268003-A1 Aqueous solution containing multilaye rinterference pigments L'OREAL (FR) 2008-10-30 US disclosed
US-20080268002-A1 Compositions for Making Up Keratinous Materials L'OREAL (FR) 2008-10-30 US disclosed
US-20080241086-A1 Line of cosmetic compositions L'OREAL (FR) 2008-10-02 US disclosed
US-20080226574-A1 Line of cosmetic compositions L'OREAL (FR) 2008-09-18 US disclosed
US-20080089917-A1 Anhydrous and non-pulverulent, including oily phase; silicones; kits L'OREAL (FR) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241086-A1 Line of cosmetic compositions CUTA, TYR, RARA TSHR 2682/4885THRB 3665/4885ALDH1A1 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.